UBS Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-40,000
| Closed | -$278K | – | 10504 |
|
|
2025
Q4 | $278K | Sell |
40,000
-14,918
| -27% | -$98.1K | ﹤0.01% | 6409 |
|
|
2025
Q3 | $354K | Sell |
54,918
-20,000
| -27% | -$137K | ﹤0.01% | 6327 |
|
|
2025
Q2 | $499K | Hold |
74,918
| – | – | ﹤0.01% | 6008 |
|
|
2025
Q1 | $485K | Buy |
74,918
+60,000
| +402% | +$431K | ﹤0.01% | 5871 |
|
|
2024
Q4 | $120K | Buy |
+14,918
| New | +$123K | ﹤0.01% | 6759 |
|
|
2024
Q2 | – | Sell |
-37,000
| Closed | -$393K | – | 9529 |
|
|
2024
Q1 | $393K | Buy |
+37,000
| New | +$324K | ﹤0.01% | 5377 |
|
|
2022
Q3 | – | Sell |
-29,500
| Closed | -$247K | – | 10333 |
|
|
2022
Q2 | $247K | Hold |
29,500
| – | – | ﹤0.01% | 4753 |
|
|
2022
Q1 | $674K | Buy |
+29,500
| New | +$721K | ﹤0.01% | 4457 |
|
|
2020
Q1 | – | Sell |
-420,000
| Closed | -$12.6M | – | 7961 |
|
|
2019
Q4 | $12.6M | Hold |
420,000
| – | – | ﹤0.01% | 1743 |
|
|
2019
Q3 | $9.18M | Buy |
420,000
+88,600
| +27% | +$2.03M | ﹤0.01% | 1835 |
|
|
2019
Q2 | $8.36M | Sell |
331,400
-23,000
| -6% | -$546K | ﹤0.01% | 1908 |
|
|
2019
Q1 | $8.75M | Sell |
354,400
-983,700
| -74% | -$23.5M | ﹤0.01% | 1780 |
|
|
2018
Q4 | $24.7M | Buy |
1,338,100
+222,800
| +20% | +$5.3M | 0.01% | 947 |
|
|
2018
Q3 | $28.6M | Sell |
1,115,300
-525,000
| -32% | -$12M | 0.01% | 968 |
|
|
2018
Q2 | $38.1M | Sell |
1,640,300
-705,700
| -30% | -$14.6M | 0.02% | 796 |
|
|
2018
Q1 | $37.3M | Buy |
2,346,000
+396,000
| +20% | +$7.37M | 0.02% | 782 |
|
|
2017
Q4 | $40.5M | Buy |
1,950,000
+1,050,000
| +117% | +$16.7M | 0.02% | 769 |
|
|
2017
Q3 | $12.9M | Buy |
900,000
+200
| +0% | +$3.02K | 0.01% | 1412 |
|
|
2017
Q2 | $15.6M | Buy |
899,800
+799,800
| +800% | +$9.59M | 0.01% | 1201 |
|
|
2017
Q1 | $1.1M | Sell |
100,000
-894,700
| -90% | -$12.3M | ﹤0.01% | 3450 |
|
|
2016
Q4 | $14.4M | Sell |
994,700
-226,100
| -19% | -$4.15M | 0.01% | 1237 |
|
|
2016
Q3 | $30M | Buy |
1,220,800
+900,900
| +282% | +$23.3M | 0.02% | 734 |
|
|
2016
Q2 | $6.44M | Sell |
319,900
-1,586,500
| -83% | -$44.9M | ﹤0.01% | 1736 |
|
|
2016
Q1 | $50.1M | Sell |
1,906,400
-1,117,600
| -37% | -$82.6M | 0.03% | 469 |
|
|
2015
Q4 | $307M | Buy |
3,024,000
+3,002,200
| +13,772% | +$337M | 0.2% | 109 |
|
|
2015
Q3 | $3.89M | Buy |
21,800
+21,600
| +10,800% | +$5.04M | ﹤0.01% | 2137 |
|
|
2015
Q2 | $44K | Hold |
200
| – | – | ﹤0.01% | 6103 |
|
|
2015
Q1 | $40K | Sell |
200
-291,800
| -100% | -$51.8M | ﹤0.01% | 6255 |
|
|
2014
Q4 | $41.8M | Buy |
+292,000
| New | +$39.3M | 0.03% | 609 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
UBS Group's BHC Position: Q1 2026 in Review
UBS Group increased its Bausch Health (BHC) stake by 72% in Q1 2026, buying an estimated $2.6M and bringing the position to 1,041,848 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3961.
UBS Group first reported a position in BHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $132M in Q4 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- UBS Group held 1,041,848 shares of Bausch Health worth $5.63M as of Q1 2026.
- UBS Group bought 434,371 Bausch Health shares in Q1 2026, an estimated $2.6M.
- Bausch Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3961 holding.
- UBS Group first reported a position in Bausch Health in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Bausch Health position peaked at $132M in Q4 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.